H.I.S.Co., Ltd.

As of April 30, 2026, H.I.S.Co., Ltd. carries a market capitalization of 414.95M, placing it among publicly traded companies globally. Its enterprise value stands at 896.04M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

H.I.S.Co., Ltd.'s next confirmed earnings release is scheduled for December 11, 2026.

As of April 30, 2026, H.I.S.Co., Ltd. has 74.76M shares outstanding.

These figures are as of April 30, 2026.

As of April 30, 2026, H.I.S.Co., Ltd. maintains a current ratio of 0.81, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended April 30, 2026.

As of the close on October 22, 2026, H.I.S.Co., Ltd.'s stock has declined approximately 16.08% over the past 52 weeks. The 50-day moving average sits at 6.22, while the 200-day moving average is 6.03.

As of April 30, 2026, H.I.S.Co., Ltd. holds 592.60M in cash and equivalents against 1.01B in total debt, resulting in a net debt position of 347.94M. Total book value stands at 328.08M, with working capital of -250.74M providing operational flexibility.

H.I.S.Co., Ltd.'s most recent stock split took place on April 25, 2014 with a 1:2 split ratio.